Breaking News - Candlesense

Methode Electronics Reschedules First Quarter Fiscal 2026 Earnings Release and Conference Call

(NYSE:MEI) CHICAGO, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Methode Electronics, Inc. (NYSE: MEI), a leading global supplier of custom-engineered solutions for user interface, lighting system and powe...

Symbol: MEI

Earnings

10 days ago

SAB BIO to Deliver Five Presentations Related to SAB-142 at the 2025 Annual Meeting of the European Association for the Study of Diabetes

(NASDAQ:SABS) MIAMI, Sept. 03, 2025 (GLOBE NEWSWIRE) -- SAB Biotherapeutics, Inc. (Nasdaq: SABS), (“SAB BIO” or the “Company”), a clinical-stage biopharmaceutical company with a novel immunothera...

Symbol: SABS

Clinical trials

10 days ago

Honoring the Legacy of Pat Graney: A Visionary Leader and Devoted Community Champion, Patrick C. Graney III Endowment Fund Contribution

(NASDAQ:METC) LEXINGTON, Ky., Sept. 3, 2025 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ: METC, METCB, "Ramaco" or the "Company") today expressed its deep respect and heartfelt remembrance to hon...

Symbol: METC

Community

10 days ago

Read more prnewswire

Couchbase Announces Second Quarter Fiscal 2026 Financial Results

(NASDAQ:BASE) SAN JOSE, Calif., Sept. 3, 2025 /PRNewswire/ -- Couchbase, Inc. (NASDAQ: BASE), the developer data platform for critical applications in our AI world, today announced financial result...

Are there any macro or competitive risks that could impact Couchbase's forward momentum? What guidance is management providing for FY2026 revenue and AI‑driven product adoption? How will Couchbase's Q2 results affect its valuation relative to sector peers?

Symbol: BASE

Earnings

10 days ago

Read more prnewswire

The Andersons, Inc. to Host 2025 Investor Day

(NASDAQ:ANDE) MAUMEE, Ohio, Sept. 3, 2025 /PRNewswire/ -- The Andersons, Inc. (Nasdaq: ANDE), announced today that it will host an Investor Day on Tuesday, December 9, 2025, in New York City. Presi...

Symbol: ANDE

Investor day

10 days ago

Read more prnewswire

WhiteFiber, Inc. to Present at the H.C. Wainwright 27th Annual Global Investment Conference

(NASDAQ:WYFI) NEW YORK, Sept. 3, 2025 /PRNewswire/ -- WhiteFiber, Inc. (NASDAQ: WYFI), a leading provider of AI infrastructure and HPC solutions, today announced that it will participate in the H.C...

Symbol: WYFI

Investor relations

10 days ago

Read more prnewswire

Meta to Participate in the Goldman Sachs Communacopia and Technology Conference

(NASDAQ:META) MENLO PARK, Calif., Sept. 3, 2025 /PRNewswire/ -- Meta, Inc. (NASDAQ: META) today announced that Susan Li, Chief Financial Officer, will participate in the Goldman Sachs Communacopia ...

Symbol: META

Finance

10 days ago

Read more prnewswire

Credo Technology Group Holding Ltd Reports First Quarter of Fiscal Year 2026 Financial Results

(NASDAQ:CRDO) SAN JOSE, Calif.--(BUSINESS WIRE)--Credo Technology Group Holding Ltd (Credo) (Nasdaq: CRDO), an innovator in providing secure, high-speed connectivity solutions that deliver improved...

What guidance and outlook does the company provide for upcoming quarters, and what are the key risks to its long‑term growth? How does Credo's Q1 FY2026 performance compare to its peers in the AI‑driven connectivity space in terms of revenue and margins? What impact will the modest 2% revenue growth have on Credo's valuation and target price?

Symbol: CRDO

Earnings

10 days ago

Hewlett Packard Enterprise Reports Fiscal 2025 Third Quarter Results

(NYSE:HPE) HOUSTON--(BUSINESS WIRE)--HPE (NYSE: HPE) today announced financial results for the third quarter ended July 31, 2025. “HPE delivered record-breaking revenue and improved profitability t...

How does HPE's current performance and acquisition strategy compare to its main competitors in the server and networking markets? How is the market likely to price in HPE's record-breaking revenue and improved profitability for the next trading session? What impact will the Juniper Networks acquisition have on HPE's future revenue and profit margins?

Symbol: HPE

Mergers

10 days ago

Personalis Announces New Data from a Landmark Neoadjuvant Lung Cancer Trial Showing Superiority of Ultra-Sensitive, Tumor-Informed MRD Testing

(NASDAQ:PSNL) FREMONT, Calif.--(BUSINESS WIRE)--Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced new data from an AstraZeneca phase 3 clinical trial ...

How does Personalis' MRD technology compare to competing platforms in terms of sensitivity, adoption by major pharma partners, and potential market share? What is the timeline for regulatory approval and commercial rollout of the NeXT Personal® MRD test in the EGFR‑mutated NSCLC market? How will the positive NeoADAURA trial data affect Personalis' revenue forecasts and stock valuation?

Symbol: PSNL

Clinical trials

10 days ago